Rational design of RAR-selective ligands revealed by RARbeta crystal stucture

Archive ouverte

Germain, Pierre | Kammerer, Sabrina | Pérez, Efrén | Peluso-Iltis, Carole | Tortolani, David | Zusi, F. Christopher | Starrett, John | Lapointe, Philippe | Daris, Jean-Paul | Marinier, Anne | de Lera, Angel R. | Rochel, Natacha | Gronemeyer, Hinrich

Edité par CCSD ; EMBO Press -

The crystal structure of the ligand-binding domain of RARbeta, a suspect tumour suppressor, reveals important features that distinguish it from the two other RAR isotypes. The most striking difference is an extra cavity allowing RARbeta to bind more bulky agonists. Accordingly, we identified a ligand that shows RARbeta selectivity with a 100-fold higher affinity to RARbeta than to alpha or gamma isotypes. The structural differences between the three RAR ligand-binding pockets revealed a rationale explaining how a single retinoid can be at the same time an RARalpha, gamma antagonist and an RARbeta agonist. In addition, we demonstrate how to generate an RARbeta antagonist by gradually modifying the bulkiness of a single substitution. Together, our results provide structural guidelines for the synthesis of RARbeta-selective agonists and antagonists, allowing for the first time to address pharmacologically the tumour suppressor role of RARbeta in vitro and in animal models.

Consulter en ligne

Suggestions

Du même auteur

Rational design of RAR‐selective ligands revealed by RARβ crystal stucture

Archive ouverte | Germain, Pierre | CCSD

International audience. The crystal structure of the ligand‐binding domain of RARβ, a suspect tumour suppressor, reveals important features that distinguish it from the two other RAR isotypes. The most striking diff...

RARβ ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis

Archive ouverte | Kammerer, Sabrina | CCSD

International audience. Retinoids have demonstrated therapeutic efficacy in the treatment of acute promyelocytic leukaemia and in the chemoprevention of a large number of cancers. As the cellular signalling pathway ...

Silicon analogues of the retinoid agonists TTNPB and 3-methyl-TTNPB, disila-TTNPB and disila-3-methyl-TTNPB: chemistry and biology.

Archive ouverte | Büttner, Matthias W | CCSD

Twofold sila-substitution (C/Si exchange) in the saturated ring of the tetrahydronaphthalene skeleton of the retinoid agonists TTNPB (1 a) and 3-methyl-TTNPB (2 a) leads to disila-TTNPB (1 b) and disila-3-methyl-TTNPB (2 b), respe...

Chargement des enrichissements...